Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary gastric lymphoma: a review of 45 cases.
Ravaioli A, Amadori M, Faedi M, Rosti G, Folli S, Barbieri C, Giorgini G, Marangolo M, Emiliani E, Amadori D. Ravaioli A, et al. Among authors: marangolo m. Eur J Cancer Clin Oncol. 1986 Dec;22(12):1461-5. doi: 10.1016/0277-5379(86)90080-5. Eur J Cancer Clin Oncol. 1986. PMID: 3595671
Treatment of pelvic osteosarcoma.
Marangolo M, Tienghi A, Fiorentini G, Dazzi C, Graziani G, Priori T, Emiliani E. Marangolo M, et al. Ann Oncol. 1992 Apr;3 Suppl 2:S19-21. doi: 10.1093/annonc/3.suppl_2.s19. Ann Oncol. 1992. PMID: 1622857 Free article.
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Scagliotti GV, Ricardi U, Crinó L, Maranzano E, De Marinis F, Morandi MG, Meacci L, Marangolo M, Emiliani E, Rosti G, Figoli F, Bolzicco G, Masiero P, Gentile A, Tonato M. Scagliotti GV, et al. Among authors: marangolo m. Cancer Chemother Pharmacol. 1996;38(6):561-5. doi: 10.1007/s002800050527. Cancer Chemother Pharmacol. 1996. PMID: 8823499 Clinical Trial.
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study.
Amadori D, Nanni O, Marangolo M, Pacini P, Ravaioli A, Rossi A, Gambi A, Catalano G, Perroni D, Scarpi E, Giunchi DC, Tienghi A, Becciolini A, Volpi A. Amadori D, et al. Among authors: marangolo m. J Clin Oncol. 2000 Sep;18(17):3125-34. doi: 10.1200/JCO.2000.18.17.3125. J Clin Oncol. 2000. PMID: 10963641 Clinical Trial.
158 results